NIH:
- Centers of Excellence in Genomic Science (RM1 Clinical Trial Optional) (PAR-23-098) National Human Genome Research Institute National Institute of Mental Health Application Receipt Date(s): June 21, 2024
- Catalytic Tool and Technology Development in Kidney, Urologic, and Hematologic Diseases (R21 Clinical Trial Not Allowed) (PAR-23-119) National Institute of Diabetes and Digestive and Kidney Diseases Application Receipt Date(s): January 07, 2025
- Development and Validation of Models for Alzheimers Disease-Related Dementias (ADRD) (R61/R33 – Clinical Trial Not Allowed) (PAR-23-154) National Institute of Neurological Disorders and Stroke National Institute on Aging Application Receipt Date(s): October 20, 2023
- Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional) (PAR-23-157) National Institute on Drug Abuse Application Receipt Date(s): Multiple dates, see announcement.
- Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Basic Experimental Studies with Humans (BESH) Required) (PAR-23-158) National Institute on Drug Abuse Application Receipt Date(s): Multiple dates, see announcement.
- Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed) (PAR-23-159) National Center for Advancing Translational Sciences Eunice Kennedy Shriver National Institute of Child Health and Human Development Application Receipt Date(s): October 17, 2024
- Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R03 Clinical Trial Not Allowed) (PAR-23-160) National Center for Advancing Translational Sciences Eunice Kennedy Shriver National Institute of Child Health and Human Development Application Receipt Date(s): October 17, 2024
- Institutional Training Programs to Advance Translational Research on Alzheimer’s Disease (AD) and AD-Related Dementias (ADRD) (T32 Clinical Trial Not Allowed) (PAR-23-163) National Institute on Aging Application Receipt Date(s): September 25, 2023
- Diagnostic Centers of Excellence (X01 Clinical Trial Not Allowed) (PAR-23-171) National Institute of Neurological Disorders and Stroke National Center for Advancing Translational Sciences National Eye Institute National Human Genome Research Institute National Heart, Lung, and Blood Institute National Institute of Allergy and Infectious Diseases National Institute of Arthritis and Musculoskeletal and Skin Diseases Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute of Dental and Craniofacial Research National Institute of Environmental Health Sciences Application Receipt Date(s): May 15, 2025
- International Research in Infectious Diseases (R01 Clinical Trial Not Allowed) (RFA-AI-23-023) National Institute of Allergy and Infectious Diseases Application Receipt Date(s): Multiple dates, see announcement.
- Strengthening Global Competency and Capacity in Inspectional Approaches for the Oversight of Human and Animal Pharmaceutical Products (U01) Clinical Trials Not Allowed (RFA-FD-23-022) Food and Drug Administration Application Receipt Date(s): June 20, 2023
- Individually Measured Phenotypes to Advance Computational Translation in Mental Health (IMPACT-MH) (U01 Clinical Trial Optional) (RFA-MH-23-105) National Institute of Mental Health Application Receipt Date(s): June 14, 2023
- Individually Measured Phenotypes to Advance Computational Translation in Mental Health (IMPACT-MH): Data Coordinating Center (U24 Clinical Trial Not Allowed) (RFA-MH-23-106) National Institute of Mental Health Application Receipt Date(s): June 14, 2023
- BRAIN Initiative: Integration and Analysis of BRAIN Initiative Data (R01 Clinical Trial Not Allowed) (RFA-MH-23-270) National Institute of Mental Health National Center for Complementary and Integrative Health National Eye Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute of Biomedical Imaging and Bioengineering Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse National Institute on Deafness and Other Communication Disorders National Institute of Neurological Disorders and Stroke Application Receipt Date(s): June 07, 2024
- BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed) (RFA-MH-23-331) National Institute of Mental Health National Eye Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute of Biomedical Imaging and Bioengineering Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse National Institute on Deafness and Other Communication Disorders National Institute of Neurological Disorders and Stroke Application Receipt Date(s): Multiple dates, see announcement.
- Emergency Awards: HEAL Initiative-Early-Stage Discovery of New Pain and Opioid Use Disorder Targets Within the Understudied Druggable Proteome (R21 Clinical Trial Not Allowed) (RFA-TR-23-010) National Center for Advancing Translational Sciences National Center for Complementary and Integrative Health National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute of Arthritis and Musculoskeletal and Skin Diseases Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse National Institute of Dental and Craniofacial Research National Institute of Neurological Disorders and Stroke Application Receipt Date(s): May 22, 2023
NIA:
- RFA-AG-24-004: Estimating the Monetary Costs of Dementia in the United States (U01 Clinical Trial Not Allowed)
- RFA-AG-24-008: Edward R. Roybal Coordinating Center (R24 – Clinical Trial Not Allowed)
- RFA-AG-24-009: Alzheimer’s Disease (AD) and AD-Related Dementias (ADRD) Real-World Data Platform (U54 Clinical Trial Optional)
- RFA-AG-24-010: Limited Competition: The Health and Retirement Study and Harmonized Cognitive Assessment Protocol (U01 Clinical Trial Not Allowed)
- RFA-AG-24-012: NIA Expanding Research in AD/ADRD (ERA) Postbaccalaureate Research Education Program (R25 – Independent Clinical Trial Not Allowed)
- RFA-AG-24-013: NIA Expanding Research in AD/ADRD (ERA) Summer Research Education Program (R25 – Independent Clinical Trial Not Allowed)